News Feature in 2021

Nature Medicine asks leading researchers to name their most anticipated clinical trial for 2022, from CRISPR and psilocybin to oncolytic viruses.

During the COVID-19 pandemic, the public have turned to scientists and doctors for vital information. But science communication is a skill in itself, so we asked the experts to share their tips.

Tracking the coronavirus SARS-CoV-2, developing treatments and testing vaccines have relied on access to the health data of millions of people. This massive trove could be used to understand other diseases, but not everyone is convinced.

The recent failure of a gene therapy for Huntington’s disease was devastating for patients, but researchers remain optimistic.

Misinformation about COVID-19 vaccines often starts life in Europe or the United States but has found fertile ground in Africa, which poses a challenge for local health leaders.

mRNA vaccines are now in the limelight as a key tool for tackling COVID-19, but the technology was originally developed for other diseases, such as cancer, that researchers are now hoping to treat.

Public-health researchers are more visible than ever before. But for some, this has led to abuse and attacks that threaten to silence them.

Although many health experts around the world must stay focused on the ongoing viral pandemic caused by SARS-CoV-2, similar viruses and microbial organisms such as bacteria could create the next global killer. Experts discuss the most likely culprits.

The pandemic has been a source of a sometimes overwhelming sense of uncertainty. We asked our readers to share how they have used art to document their experiences.

There has been a lot of hype around the applications of machine learning in medicine. But how is machine learning actually helping bench-to-bedside scientists and clinicians do their jobs?